There is currently a lack of real‐world clinical data regarding the safety and efficacy of coronavirus disease 2019 (COVID‐19) vaccines with respect to plaque psoriasis treatment involving tumor necrosis fact or (TNF)‐α and interleukin (IL‐17A) inhibitors. The gene discussed is IL17A; the disease is psoriasis vulgaris.